查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1479955

眼压计市场 - 2024 年至 2029 年预测

Tonometer Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 136 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

眼压计市场预计将从2022年的312,281,000美元成长到2029年的410,489,000美元，复合年增长率为3.98%。

使用眼压计（一种携带式医疗设备）测量眼球内的眼压和眼内液压力。眼压计由一个平头探头和一个金属柱塞组成，可以轻轻地刷过眼表。

在严重的情况下，青光眼会损害视神经并导致失明。眼压计不需要使用萤光素或局部麻醉剂，减少了感染疾病和角膜擦伤的风险。因此，它经常在医院、眼科诊所和眼科中心使用。

市场驱动因素：

  • 眼压计市场的预期扩张

青光眼在一般人群中盛行率的增加是眼压计市场扩大的主要因素之一。老年人和糖尿病患者数量的增加加剧了眼压计需求的快速成长。

医疗机构越来越多地使用阿普拉纳西翁眼压计也推动了眼压计市场的成长。此测试通常用于测量眼内压 (IOP)，以确定暂时压平部分角膜所需的功率。此外，回弹眼压计的进步正在推动眼压计市场的成长。

  • 老年人和糖尿病患者的生长

近年来，人均寿命延长，老年人口数量不断增加。从急性疾病转变为慢性疾病的转变，包括糖尿病、关节炎、高胆固醇和高血压，是导致人类寿命下降的原因。

根据2019年联合国全球老化调查，到2050年，全球将有15亿人年龄在65岁或以上。老年病和其他慢性病的盛行率预计将随着人口的增长而上升，从而推动全球眼压计市场的扩张。

  • 增加眼科检查营

及早发现和识别眼部疾病，包括青光眼和其他导致眼睛损伤的慢性疾病，可以预防视力丧失和失明。这种疾病的征兆可以在定期眼科检查中发现。

青光眼在早期阶段不会表现出任何特殊症状或警讯。因此，为了预防青光眼，提高大众对青光眼的认识非常重要。定期眼科检查和避免视力丧失的措施将进一步推动全球眼压计市场。

  • 扩大脉动眼压测试的使用

眼内压测试测量眼球内的眼内液压力。此测试测量暂时压平角膜的一部分所需的压力大小。它用于诊断青光眼，并刺激了眼压计市场。

压平眼压计，例如卡尔蔡司製造的压平眼压计，是眼压计的黄金标准，基于 Goldman 教授提出的想法精确测量眼内压。眼压测量对于许多眼科疾病尤其是青光眼的诊断和治疗至关重要。

此外，与其他眼压计设备的比较研究强调了其在诊断青光眼方面的有效性，并且预计对 Aplanacion 眼压计的需求将会增加。例如，2022 年 8 月发表在《加拿大眼科杂誌》上的一项研究发现，与压平眼压测量设备相比，手持式眼压测量设备经常低估眼压 (IOP)。

手持式眼压计低估眼压可能导致青光眼诊断不足和治疗不足，从而导致不可逆转的视力丧失。因此，由于阿普拉纳西翁眼压计市场预计将显着成长，与手持式眼压计相比，阿普拉纳西翁眼压计往往会高估眼内压。

  • 增加青光眼筛检项目

商业、半私营和公共医疗保健部门计划增加的青光眼筛检计划预计将在预测期内推动眼压计行业的发展。对眼压计的需求是由于人们对青光眼及其对视力的影响的了解不断增加而引起的，而眼科筛检营的数量不断增加。

眼科检查项目的增加预计也将推动眼压计市场的成长。例如，「愿景2020：视力权-印度」组织了全国社区眼科会议，并组织了免费眼科检查诊所，为眼科实践及其成功提供平台。

  • 桌上型眼压计预计将成长

动态轮廓眼压计 (DCT) 和眼反应分析仪 (ORA) 等桌面眼压计不依赖角膜的生化特性，用于测量眼压。随着越来越多的眼科手术（例如角膜移植、青光眼、白内障和其他屈光矫正手术）的进行，眼压计市场预计将会发展。

为了有效治疗这些疾病并节省未来的医疗费用，眼压测量伴随着对角膜动态特性的彻底分析。市售可携式眼压计包括回弹眼压计、Perkins 眼压计和张力笔。在预测期内，携带式眼压计的便携性、易用性和患者舒适度等因素预计将推动眼压计市场的成长。

  • 扩大患者对早期诊断的了解

眼压计市场预计将受到患者对早期诊断和定期眼压（IOP）监测以防止不必要的视力丧失的认识的推动。一旦推出优惠的支付规则，医院和诊所眼压计的使用预计将会增加。

例如，简单且复杂的眼压计（例如帕斯卡动态轮廓眼压计）在美国属于 III 类 CPT 0198T，并由保险公司 United Healthcare 承保。

  • 北美眼压计市场预计将扩大。

预计在预测期内，北美将主导眼压计市场。由于大公司的存在、青光眼的高盛行率以及完善的医疗保健系统，该地区的眼压计市场正在扩大。

例如，根据墨西哥卫生署2022年11月发布的报告，同年墨西哥青光眼患者人数估计为150万人。这种疾病在60岁以上的人中最常见。此外，据报导，墨西哥最常见的青光眼类型是原发性开角型青光眼。因此，该国青光眼的严重流行导致对眼压计的需求增加，预计市场在预测期内将大幅成长。

增加研究合作和政府支持措施也是预计推动眼压计产业扩张的其他因素。由于有利的医疗保健法律、庞大的患者基础和成熟的医疗保健行业，预计美国将占据眼压计市场的最高份额。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章眼压计市场：依技术分类

  • 介绍
  • 压平眼压测定
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 压痕眼压计
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 回弹眼压测量
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 其他技术
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力

第六章眼压计市场：依便携式类型

  • 介绍
  • 桌面
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 手持式
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力

第七章眼压计市场：依最终用户分类

  • 介绍
  • 医院
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力
  • 眼科中心
    • 市场趋势和机会
    • 成长前景
    • 地域获利能力

第八章眼压计市场：按地区

  • 介绍
  • 北美洲
    • 依技术
    • 按便携类型
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 依技术
    • 按便携类型
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 依技术
    • 按便携类型
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 依技术
    • 按便携类型
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 依技术
    • 按便携类型
    • 按最终用户
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Haag-Streit
  • HEMC Medical
  • Reichert Technologies
  • Diaton
  • Jaggi Brothers
  • Advin Healthcare
  • Keeler
  • Takagi Japan
  • Inami
  • Nidek-Intl
简介目录
Product Code: KSI061613608

The Tonometer market is projected to witness a compound annual growth rate of 3.98% to grow to US$410.489 million by 2029, from US$312.281 million in 2022.

The intraocular and fluid pressure inside the eye is measured using a tonometer, a portable medical device. It consists of metal plunger-equipped flat-tipped probes that are gently brushed on the eye's surface.

It is used to identify and evaluate those at risk of glaucoma, which, in severe cases, can harm the optic nerve and result in blindness. Tonometers don't need fluorescein or topical anesthetic to use, and they lessen the risk of getting infections and corneal abrasions. As a result, hospitals, eye clinics, and ophthalmic centers frequently employ them.

MARKET DRIVERS:

  • Prospects for the tonometer market to expand

The increased prevalence of glaucoma among the general population is one of the primary drivers of the tonometer market rise. Further fueling the surge in tonometer demand is the growing elderly and diabetic populations, who are more vulnerable to eye-related conditions.

The increased use of applanation tonometry in healthcare facilities is also fueling tonometer market growth. The test is frequently used to determine intraocular pressure (IOP) since it determines how much power is required to temporarily flatten a section of the cornea. Additionally, rebound tonometry's advancement is promoting tonometer market growth.

  • Growth in geriatric and diabetic patients

Since the population's life expectancy has grown over the past several years, there are more elderly people in society. A change from acute to chronic disorders including diabetes, arthritis, high cholesterol, and hypertension, is the reason for the decrease in life expectancy of humans.

According to a 2019 United Nations World Ageing study, there will be 1.5 billion people who are 65 years of age or older worldwide by the year 2050. The prevalence of geriatric and other chronic illnesses would rise along with the population, which will propel the expansion of the worldwide tonometer market.

  • Increased number of eye check-up camps

Vision loss and blindness might be avoided via early identification of and detection of ophthalmic disorders including glaucoma and other chronic diseases causing eye difficulties. The signs of the disorders might be identified with routine eye exams.

Glaucoma does not initially exhibit any particular symptoms or warning signals. Therefore, raising public knowledge of the condition may be crucial in preventing it; regular eye exams and measures to avoid vision loss further boost the worldwide tonometer market.

  • The growing use of applanation tonometry

The applanation tonometry test determines the eye's intraocular fluid pressure. The test measures the pressure needed to temporarily flatten a section of the cornea. It is employed in glaucoma diagnosis and is fueling the tonometer market.

The gold standard in tonometry, applanation tonometers from firms like Carl Zeiss give accurate measures of intraocular pressure (IOP) based on the idea presented by Professor Goldmann. IOP measurement is an essential part of the diagnosis and treatment of many eye diseases, particularly glaucoma.

Additionally, the demand for applanation tonometry is anticipated to rise due to comparative studies with other tonometry devices, highlighting its effectiveness in diagnosing glaucoma. For example, research published in the Canadian Journal of Ophthalmology in August 2022 revealed that handheld rebound tonometry devices often underestimate intraocular pressure (IOP) when compared to applanation tonometry.

This underestimation of IOP with handheld rebound tonometry may result in the underdiagnosis and undertreatment of glaucoma, leading to irreversible vision loss. Consequently, the market is expected to experience significant growth as a result of applanation tonometry's tendency to overestimate IOP compared to handheld rebound tonometry.

  • The rising number of glaucoma screening programs

A rise in glaucoma screening programs planned by the commercial, semi-public, and public healthcare sectors is anticipated to promote tonometer industry development throughout the projected period. The need for tonometers is driven by the growth in knowledge of glaucoma and its effects on vision brought on by the growing number of eye checkup camps.

Increased eye screening programs are also anticipated to promote tonometer market growth. For instance, Vision 2020: The Right to Sight - India conducted a national conference on community ophthalmology and held free eye screening clinics to provide a platform for eye care practices and their successful administration.

  • Desktop tonometers are expected to grow

IOP is measured using desktop tonometers like the Dynamic Contour Tonometer (DCT) and Ocular Response Analyzer (ORA), which are not reliant on the biochemical characteristics of the cornea. The tonometer market is anticipated to develop as more eye procedures including keratoplasty, glaucoma, cataract, and other refractive operations are performed.

To effectively treat these diseases and save on future medical expenses, IOP measurements are being accompanied by a thorough analysis of the cornea's biomechanical features. Commercially available portable tonometers include rebound tonometers, Perkins tonometers, and tono-pens. Throughout the forecast period, factors such as the portable tonometer's portability, ease of use, and improved patient comfort are anticipated to propel the tonometer market growth.

  • Greater patient understanding of the early diagnosis

The tonometer market is expected to be driven by increased patient awareness of early diagnosis and routine intraocular pressure (IOP) monitoring to prevent unnecessary vision loss. If beneficial payment rules are put in place, tonometer use in hospitals and clinics is anticipated to increase.

For instance, the cost of both simple and complex tonometers, such as the Pascal dynamic contour tonometer, is covered by insurance carrier United Healthcare in the United States under Category III CPT 0198T.

  • It is projected that the North American tonometer market will expand.

North America is predicted to dominate the tonometer market during the forecast period. The tonometer market is expanding as a result of the existence of large businesses, the high rate of glaucoma in the region, and the established healthcare system.

For example, according to a report released by the Ministry of Health in Mexico in November 2022, it is estimated that there are 1.5 million individuals living with glaucoma in Mexico in the same year. This condition is predominantly observed in individuals aged 60 and above. Furthermore, the most prevalent form of glaucoma in Mexico is reported to be open-angle primary glaucoma. Consequently, the substantial prevalence of glaucoma cases in the country leads to an increased demand for tonometers, which is expected to drive significant market growth throughout the projected period.

Growth in the number of research collaborations as well as supportive government initiatives are some other factors projected to fuel the tonometer industry expansion. The United States is anticipated to hold the highest share in this tonometer market as a result of beneficial healthcare laws, a sizable patient base, and an established healthcare industry.

Market Key Developments

  • In May 2023, The Tono-Vera(R) Tonometer with ActiViewTM Positioning System was launched by Reichert Technologies, a division of AMETEK, Inc., a pioneer in the field of eye care diagnostic equipment.
  • In April 2023, NIDEK responded to the market's growing demand for tonometer and ensured NIDEK's dependability by introducing the NT-1/1e Non-Contact Tonometer without a pachymetry feature.
  • In March 2022, iCare Home2, the Self-tonometer was approved by FDA. IOP readings are being collected with the iCare Home2 even while a patient is lying down.

Segmentation:

By Technology

  • Applanation Tonometry
  • Indentation Tonometry
  • Rebound Tonometry
  • Other Technologies

By Portability Type

  • Desktop
  • Handheld

By End-User

  • Hospitals
  • Ophthalmic Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. TONOMETER MARKET, BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Applanation Tonometry
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Indentation Tonometry
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Rebound Tonometry
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Other Technologies
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. TONOMETER MARKET, BY PORTABILITY TYPE

  • 6.1. Introduction
  • 6.2. Desktop
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Handheld
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. TONOMETER MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Ophthalmic Centers
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. TONOMETER MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technology
    • 8.2.2. By Portability Type
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Technology
    • 8.3.2. By Portability Type
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Technology
    • 8.4.2. By Portability Type
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Technology
    • 8.5.2. By Portability Type
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Technology
    • 8.6.2. By Portability Type
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Haag-Streit
  • 10.2. HEMC Medical
  • 10.3. Reichert Technologies
  • 10.4. Diaton
  • 10.5. Jaggi Brothers
  • 10.6. Advin Healthcare
  • 10.7. Keeler
  • 10.8. Takagi Japan
  • 10.9. Inami
  • 10.10. Nidek-Intl